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Abstract
Takotsubo cardiomyopathy (TTC) is characterized by a systolic dysfunction localized in the apical and medial aspect of
the left ventricle. It is usually related to physical or emotional stress. Recent evidence highlighting the role of infection
led us to analyze the links between TTC and sepsis. A systematic review of the literature was undertaken to assess any
trends in clinical findings, diagnosis, and outcomes in such patients. We identified 23 selected papers reporting a total of
26 patients, having sepsis, in whom TTC occurred. For each case, we collected data identifying population characteristics,
source of sepsis, clinical disease description, and the results of cardiovascular investigations. The majority of patients
were females (n ¼ 16), mean age was 62.8 (14.0 standard deviation) years, and clinical outcome was favorable in 92.3% of
the cases once the management of sepsis was initiated. A better understanding of the mechanisms of sepsis-associated
TTC may generate novel strategies to treat the complications of this cardiomyopathy and may even help predict and
prevent its occurrence.
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Introduction
Takotsubo cardiomyopathy (TTC) is an increasingly recog-
nized cardiac condition that is also known as apical balloon-
ing syndrome or broken heart syndrome. It has been classified
by the American Heart Association as both a primary and an
acquired cardiomyopathy1 and is listed by the European Soci-
ety of Cardiology (ESC) as an unclassified cardiomyopathy.2
It has been described by transient midsegmental left ventri-
cular (LV) dysfunction that may involve the apex, which can
mimic the shape of a trap used by Japanese fishermen for
octopus fishing (hence the name). Takotsubo cardiomyopathy
was first mentioned by Sato et al in 1990 reporting the picture
of a takotsubo-shaped heart during ventriculography.3 The
main characteristic of TTC, especially in its initial period, is
a transient apical ballooning with regional abnormalities
sometimes spread to the midventricular segments. This is also
known as the classical presentation of TTC. Additionally, a
‘‘reverse’’ takotsubo exits where there is akinesis of the basal
segments with a normal apex, although this is uncommon
(<20%).2
Takotsubo cardiomyopathy is more prevalent in females
and usually occurs in combination with a stressful event;
associations with different triggers (eg, infections and
neurological conditions) have also been reported.4,5 Takot-
subo cardiomyopathy typically carries a favorable prognosis
with full recovery of LV function, although serious complica-
tions may rarely arise. The underlying pathophysiology of
TTC has not been fully clarified, although the enhanced cen-
tral and local sympathetic stimulation are consistently
described.4 Since sepsis can be considered as a significant
stressful event, our systematic review aims at gathering the
evidence of reported cases concerning the onset of TTC in
patients with sepsis.
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Definition of TTC
There is as yet no consensus on the diagnostic criteria for TTC.
Researchers at the Mayo Clinic proposed diagnostic criteria in
2004, which were modified in 2008.6,7 Taking into account
these 2 main classifications, the TTC is defined as:
1. Transient abnormalities of LV contraction during ven-
triculography with akinesia of the apical part and hyper-
kinesis of the base (midapical form). In the majority of
cases, the coronary arteries lack relevant flow obstruc-
tion. Nevertheless, concomitant coronary artery disease
does not exclude takotsubo syndrome.
2. The definition has to include also patients with different
ventricular contraction patterns such as midventricular
transient contraction abnormalities, presenting with
hyperkinesis of the base and apex of the LV and akine-
sia of the midventricular part (midventricular form).
Also, the ‘‘inverted’’ type with hyperkinesis of the apex
and transient basal akinesia of the heart has to be
included (midbasal form).
3. In patients with TTC, the motion abnormalities resolve
in the following few weeks.8 However, in some
patients, the process of resolving motion abnormalities
may be as long as 1 year9; for this reason, constant
monitoring is important in patients with TTC.
4. Changes in the electrocardiogram (ECG) indicative of
myocardial ischemia most often presented in the chest
leads V1 to V6 but may also be present in the limb
leads. The most common changes are sinus tachycardia
and ST-segment elevation in the chest leads with evol-
ving T-wave inversions in nearly all leads. These
changes resolve with passing time, and changes persist-
ing over a certain time frame other than T-wave inver-
sion are rare.
5. Exclusion of pheochromocytoma or myocarditis.
According to the Mayo Clinic criteria, this definition
also includes physical stressors such as seizures, major
trauma, and stroke.10
Methods
Study Objectives
The objective of this systematic review is to summarize the
available evidence for the development of TTC during sepsis.
In particular, (1) we attempt to highlight the main microorgan-
isms involved in TTC when sepsis occurred, (2) compare and
contrast the symptoms of this cohort study with these of non-
septic patients with TTC, (3) evaluate the risk factors presented
in the cases reviewed, (4) study the ECG changes of the cases
reviewed and find similarities and differences in nonseptic
patients with TTC, (5) evaluate changes in cardiac and hemo-
dynamic biomarkers in order to offer clinicians useful guidance
in cases of septic patients with TTC, (6) assess the main find-
ings obtained from the diagnostic procedures, and (7) present
the outcome of the cases reviewed and find differences in non-
septic patients with TTC.
Literature Search
A literature search was performed using PubMed, Embase, and
MEDLINE using combinations of the terms ‘‘takotsubo’’ or
‘‘tako-tsubo’’ or ‘‘takotsubo syndrome’’ or ‘‘takotsubo cardio-
myopathy’’ or ‘‘left ventricular apical ballooning’’ or ‘‘broken
heart syndrome’’ or ‘‘stress cardiomyopathy’’ and ‘‘sepsis’’ or
‘‘sirs’’ or ‘‘systemic inflammatory response syndrome’’ with
the limitations ‘‘humans’’ and ‘‘English language.’’
The last date for this search was February 18, 2016. Figure 1
outlines our search strategy. All studies are listed in Table 1.
Inclusion and Exclusion Criteria
Relevant publications were identified on the basis of titles and
abstracts using the following inclusion and exclusion criteria.
Figure 1. Flow diagram for systematic search.
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Inclusion criteria were (1) patients with takotsubo syndrome
described as also having sepsis, (2) the study population had
culture-proven sepsis or suspected infection based on clinical
algorithm, and (3) the manuscript evaluated TTC using ima-
ging and/or instrumental techniques. The following publication
types were excluded: reviews, meta-analyses, commentaries,
non-English articles, conference publications, in vitro studies,
animal studies, and guidelines.
The references of the excluded articles were reviewed to
identify any additional relevant studies. The retrieved studies
were carefully examined to exclude potentially duplicate or
overlapping data. Abstracts were excluded from the analysis
because non–peer-reviewed data may introduce bias into the
study.
Data Extraction and Validity Assessment
Two independent reviewers (T.A. and S.C.) independently per-
formed the literature search to identify relevant studies. A third
investigator (M.A.) was available for arbitration in the event of
discordance. Relevant data on authors, country, year of publi-
cation, patient population, age, gender, microorganisms
involved, time interval between admission and TTC onset, type
of takotsubo, cardiac enzymes, ECG changes, echocardiogram/
coronary angiography/left ventriculography findings, ejection
fraction (EF), previous risk factor for cardiovascular diseases,
symptoms at admission, and outcomes were extracted and pre-
sented in Tables 1 and 2.
Results
Selected Studies
Of 245 potentially relevant manuscripts, 23 were selected for
final review (Figure 1). Baseline demographic characteristics
of the included studies are shown in Table 1. A total amount of
26 patients were reviewed. Most patients were female (n¼ 16),
mean age was 62.8 (14.0 standard deviation) years, and the vast
majority presented with the typical, apical-involving pattern
(84.6%).
Sepsis and TTC
Bacterial sepsis was the most frequent cause of TTC in our
systematic review (57.7%). Moreover, 7 (26.9%) cases were
described without providing any pathogenic microorganism;
2 (7.8%) cases were related to viral agents; in 1 (3.8%) case,
sepsis was due to a fungus; and finally, in 1 (3.8%) further case,
the culture results were negative, and the diagnosis of sepsis
was based on clinical criteria.
Historically, the association between TTC and sepsis was
first described in 2005 by Park et al34 on 92 patients admitted to
intensive care units and in which sepsis was the only variable
associated with the onset of LV apical ballooning (odds ratio¼
9.2; 95% confidence interval ¼ 2.4-35.8, P < .001). In 2012,
El-Sayed and his colleagues,35 in their study on data of 24 701
patients diagnosed with TTC, showed that sepsis increased the
risk of TTC development. A recent Italian study,36 performed
on a smaller group of 26 patients with TTC, suggested the role
of pulmonary infections and showed that sepsis was the com-
plication in 31% of patients with TTC.
Our study showed that the majority of bacterial sepsis was
sustained by Escherichia coli (n ¼ 3). Other bacteria mainly
involved were Klebsiella pneumoniae and Staphylococcus aur-
eus (n ¼ 2 each one).
Concerning the cases of sepsis and TTC sustained by viral
agents, we found only 2 cases in which sepsis was due to
cytomegalovirus (CMV) and human herpesvirus 6 (HHV-6),
respectively.12,14 The pathophysiological mechanisms underly-
ing the damage are different; in herpes virus infections (CMV
and HHV-6), the cause of myocardial cell damage is primarily
an immune-mediated reaction.37
Among the cases reviewed, only one was related to a para-
sitic infection (babesiosis). In babesiosis, infected erythrocytes
cause vascular stasis, leading to microvascular obstruction, tis-
sue anoxia, and ischemia.22 These findings were confirmed, in
other studies, using animal models, describing cases of cardi-
omegaly, myocarditis, and multifocal coagulation cardiac
necrosis.22 The authors hypothesized that there may be an
association between babesiosis and TTC.
With regard to the diagnostic procedures adopted to identify
such microorganisms, the main techniques were blood and
urine cultures. Positive blood culture was recorded in
13 patients, negative in 1 patient; positive urinary culture was
recorded in 8 patients; other diagnostic methods used consisted
of polymerase chain reaction (PCR; n ¼ 2), antibodies immu-
noglobulin (Ig) M/IgG (n ¼ 1), endotracheal tube aspirate
(n ¼ 1), and dialysate culture (n ¼ 1). In 6 cases, authors did
not provide information on the diagnostic methods.
Summarizing, TTC in patients with sepsis has been
observed independently from the microorganism responsible
for it. Although TTC could be related to sepsis due to bacteria,
virus, parasites, and fungus, we found a significant frequency
of case related to bacterial infection.
Cardiovascular Risk Factors and Symptoms
of Presentation
The available scientific literature shows that a great variety of
factors can predispose, trigger, and eventually result in TTC.38
These factors can be classified as triggers (eg, emotional stres-
sors, physical stressors, and neurologic triggers), pathogenic
mechanisms (eg, increased catecholamine levels and coronary
vasomotor abnormalities), and predisposing factors (eg, cardi-
ovascular risk factors). Although different studies have
reported data on precipitating events and pathogenic mechan-
isms in septic and nonseptic patients presenting with TTC,39,40
there is still a paucity of data on risk factors.
Generally, patients with TTC have a prevalence of cardio-
vascular risk factors higher than the general population and
similar to that seen in patients with acute myocardial infarction
(MI).41 Two important studies showed an unexpected high
prevalence of cardiovascular risk factors, in spite of the
absence of obstructive coronary artery disease.41,42 The main
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risk factors in nonseptic patients were described as hyperten-
sion (54%), dyslipidemia (32%), smoking (22%), diabetes
(17%), and obesity (17%); similar prevalence were observed
by Summers et al.42
Concerning the cardiovascular risk factors in sepsis-induced
TTC, these were found in 17 (65.3%) patients: the most com-
mon were diabetes type II (38.5%), hypercholesterolemia
(15.4%), and hypertension (7.7%). Four (15.4%) patients had
no cardiovascular risk factors; in 9 patients, the authors did not
report this information. The frequency of cardiovascular risk
factors encountered in our study is presented in Figure 2.
In conclusion, taking into account the sample differences
between our study and the others analyzed for nonseptic
patients, it seems that diabetes is strongly related to TTC and
that hypertension and dyslipidemia are less frequently encoun-
tered in septic than in nonseptic cohort.
Furthermore, 3 patients had associated diseases (hyperthyr-
oidism, cancer, and pheochromocytoma, respectively), which
may also have contributed to the induction of TTC. Indeed,
some of these comorbidities are known to be associated with
excessive catecholamine production and could represent the
potential link with the TTC.
With regard to the symptoms, it was shown that the most
common presenting cardiovascular symptoms in patients with
sepsis having TTC were dyspnea, fever, and chest pain (see
Table 1). These symptoms are quite similar, with the exception
of the fever that was not described, to the ones reported in
nonseptic patients presenting with TTC. Indeed, main symp-
toms in nonseptic patients are described as chest pain, followed
by dyspnea, palpitations, and physical fatigue.10,43 These
symptoms are commonly characterized by a preceding physical
or emotional stress such as a surgical operation.
Finally, in the time interval of TTC onset from the admis-
sion to the hospital, we observed the following: 11 patients
developed TTC within 24 hours from the recovery; 2 patients
within 48 hours, and 3 patients within 96 hours. We could not
establish the time interval between admission and development
of TTC in 10 cases. The short-time interval between admission
and TTC needs to be pointed out as an important consideration
for the clinicians to be aware of this TTC characteristic.
Electrocardiogram Changes
Since the majority of patients with TTC presented to the emer-
gency department with symptoms mimicking an acute coron-
ary syndrome, ECG represents a fast and reliable tool for
establishing the diagnosis of myocardial ischemia. During
TTC, changes in the ECG are a common feature most often
reported from the chest leads.11,22
In our review, we found that ECG abnormalities were often
observed after admission and the most common were (in des-
cending order) ST-segment elevation (n ¼ 15), sinus tachycar-
dia (n ¼ 10), T-wave inversion (n ¼ 7), QTc (n ¼ 2), ST
‘‘anomalies’’ (n ¼ 2), and atrial fibrillation (AF; n ¼ 1). In
3 cases, ECG changes were not described.
In particular, leads representing the anterior wall of the left
ventricle (eg, V1-V6) are often affected during the acute phase
of the TTC; these anomalies normalize, usually, in a few hours.
Following the ST-segment elevation, sinus tachycardia and
T-wave inversion are the major ECG anomalies reported in
nonseptic patients with TTC and are present in almost all chest
and limb leads.
There is persuasive evidence that T-wave inversion is not an
evolution of ST-segment elevation but, especially in the Cau-
casian population, could be present from the beginning of TTC
pathophysiology,44,45 and a prolongation of the QT interval is
more common after a few days and can persist months after
discharge.
Moreover, attenuation of the QRS complexes, albeit not
commonly noticed on routinely performed ECGs, is common
in the acute phase of the takotsubo syndrome46 and is related to
systolic dysfunction.47
Another feature reported is the prolongation of the corrected
QT interval (QTc). Complications can arise through these var-
iations in the ECG like ventricular or AF, and these changes
can be life threatening with fatal prognosis. For example, a case
of AF in an 84-year-old man presenting with a midbasal TTC
has been included in this study.
Finally, the ECG changes described are similar to those of
ST-segment elevation myocardial infarction (STEMI). In order
to differentiate the diagnosis between TTC and STEMI, the
observation of the absence of ST-segment elevation in V1 and
the presence of ST-segment depression in aVR (ST-segment
elevation in aVR) has been proposed.43 Yoshikawa reported
differences in the distribution of ST-segment elevation
between patients with TTC and those with STEMI. Most
patients with anterior acute MI had ST-segment elevation in
leads V2 to V4. In contrast, in patients with TTC, ST-segment
elevation most frequently occurred in leads II, III, aVF, aVR,
and V5 to V6 facing the apical and inferolateral regions.
Figure 2. Frequency of risk factors among patients with sepsis having
takotsubo cardiomyopathy. One risk factor indicates diabetes type II,
hypertension, cancer, pheochromocytoma, or intravenous drug
abuse. Two risk factors indicate diabetes type II þ hypercholestero-
lemia, diabetes type II þ hypertension, hypertension þ hypercholes-
terolemia. Three risk factors indicate hypertension þ alcohol abuse þ
cancer; hypertension þ previous stroke þ hyperthyroidism.
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Cardiac and Hemodynamic Biomarkers
During initial presentation to the hospital, most of the patients
have normal or mild elevated biomarkers of myocardial necro-
sis such as troponin I (TnI), troponin T (TnT), creatine kinase
(CK), and creatine kinase muscle brain (CKMB). Some
patients even present with normal concentrations of the corre-
sponding necrosis biomarkers of the myocardium, despite
severe symptoms or transient wall motion defects in the ven-
triculography or echocardiography mimicking myocardial
ischemia.11,21
From our review, we observed that cardiac enzymes were
provided in 73% of the cases. Among these cases, the TnI
enzyme was elevated in 10 patients, CKMB in 9 patients, and
TnT and CK in 5 and 3 patients, respectively (see Table 3 for
descriptive statistics).
Hemodynamic biomarkers, especially brain natriuretic pep-
tide (BNP) and its more stable variant N-terminal pro-brain
natriuretic peptide (NT-proBNP), are important to monitor the
severity and the clinical course of patients with TTC. Despite it
was described that patients with a high BNP or NT-proBNP
concentration are more likely to have an adverse outcome
reflecting the fact of diminished EF and hemodynamic impair-
ment,48 in our review, we have not recorded cases with high
levels of BNP and/or NT-proBNP that had an adverse outcome.
On the other hand, declining BNP levels might be a valuable
marker showing the improvement in LV function in patients
with TTC over time.48
In the studies reviewed, NT-proBNP and BNP levels were
provided in only 3 and 2 cases, respectively (see Table 3 for
descriptive statistics).
Our analysis of biomarker levels was not able to distinguish
whether TTC is due to sepsis. The important role of these
biomarkers in the differential diagnosis between TTC and acute
coronary syndrome leading to MI must be highlighted.
In fact, acute coronary syndrome with ST-segment elevation
and the subsequent risk of STEMI is noted as one of the most
common diseases that require to be differentiated from TTC.
The differential diagnosis can be based on the presence of
relatively remarkable elevation of the concentration level of
BNP compared with TnT; for this reason, Ahmed et al pro-
posed the BNP–TnT ratio as a potential and useful tool for
differential diagnosis.49
Moreover, the pattern of troponin elevation differs consid-
erably from acute STEMI. Usually, peak TnT levels in TTC are
modest, mean about 60-fold the upper limit of normal (ULN,
defined as 99th percentile) as opposed to >400-fold the ULN
for acute STEMI, similar to those seen in non–ST-segment
elevation MI.49,50
In conclusion, the patterns of biomarker elevations observed
are noteworthy, but there is no threshold identified that has
clinically meaningful sensitivity or specificity to distinguish
acute MI from TTC. Clinicians should take this limit into
account when interpreting such data.
Diagnostic Methods
Cardiac imaging studieswere carried out using echocardiography,
coronary angiography, and/or left ventriculography. Echocardio-
gram is an important diagnostic procedure performed to diagnose
and monitor the transient changes in systolic function. This pro-
cedure is also used to assess the valve hemodynamics and the
diastolic function of these patients.13,22 The mitral regurgitation
described in some cases could be explained by the outflow tract
obstruction due to the hyperkinesia of the base of the ventricle.
In our review, echocardiograms were performed in 69.2% of
the patients, and the main findings are reported in Table 2.
With regard to coronary angiography, patients usually
undergo this procedure due to the fact that initial presentation
of TTC can mimic an acute coronary syndrome. Coronary
angiography is followed in the majority of cases by a left ven-
triculography; furthermore, as shown in Table 2 and Figure 3,
most patients have no coronary artery disease that could
explain the wall motion abnormalities. Nevertheless, concomi-
tant coronary artery disease may not be directly related to
underlying TTC because the wall motion defects are often not
located in the territory of a single coronary artery.
Coronary angiography and left ventriculography have been
carried out in 76.9% and 42.3%, respectively, of the cases
reviewed. Interestingly, coronary angiography showed normal
arteries in 80% of the cases analyzed.
With regard to the type of TTC, the imaging studies showed
that the midapical involvement was prevalent, being observed
in 92.3% of the patients compared with the midbasal form that
was present only in 7.7% of the patients.
The EF was between 20% and 45% (average ¼ 30.9;
median ¼ 30). In 13 cases, the EF was not reported.
Finally, we carried out some comparison statistical analysis
on the relationship between type of TTC and sex and results of
coronary angiography (normal vs pathological); the results are
shown in Figure 3.
Outcome and Comparative Analysis
The prognosis of TTC is more often favorable. The prevalence
of prehospital mortality is unknown but should not be
Table 3. Descriptive Analysis of the Enzymatic Values in Patients
With Sepsis Having Takotsubo Cardiomyopathy.a
Range Mean
Minimum Maximum Average SD
TnI, ng/mL 0.44 34.6 9.23 11.17
TnT, ng/mL 0.39 2850 701.7 1233.08
CK, IU/L 251 475 394.3 124.45
CKMB, IU/L 31 154 84.7 62.97
CKMB, ng/mL 4.3 75.98 24.5 25.98
BNP, pg/mL 1860 2547 2203.5 485.78
NT-proBNP, pg/mL 3500 8680 5623.3 2713.19
Abbreviations: BNP, brain natriuretic peptide; CK, creatine kinase;
NT-proBNP, N-terminal pro-brain natriuretic peptide; SD, standard deviation;
TnI, troponin I; TnT, troponin T.
aData were rounded to the second decimal place.
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underestimated, as mortality during the acute phase in hospi-
talized patients is 4% to 5%, which is similar to the mortality
seen in patients with STEMI. Moreover, despite the recovery of
LV function and absence of coronary artery disease, mortality
after hospital discharge is notably higher than that in age-
matched healthy populations.51 Furthermore, in the largest
published cohorts, the in-hospital mortality (IHM) was 6.8%
in Japan,52 4.2% in the Unites States,53 2.6% in Italy,54 and
2.2% in Germany and Austria.55
In the cases reviewed, clinical outcome was favorable in
92.3% of these, and all the survived patients were discharged
after an average of 19 days (median¼ 17.5). Unfortunately, for
16 cases, data on the time interval to discharge were not
provided.
Interesting findings have been obtained from the compari-
son of the outcome (survived vs died patients) and sex, risk
factors (presence or absence), coronary angiography results
(normal vs pathological findings), and time interval between
admission and TTC. Results are shown in Figure 4.
Discussion
Takotsubo Cardiomyopathy and Sepsis—How Common
Is It?
Defining the exact frequency of TTC among patients with sep-
sis is difficult because of the lack of reliable epidemiological
data. With the exception of the above reported case reports,
only 3 studies described the association between sepsis and
TTC in a cohort of patients. Park et al34 reported 25 cases of
sepsis in which TTC was detected in 16 (68%) patients. Lee
et al56 described 56 patients with TTC; sepsis was considered
the cause in 15 (27%) cases. Finally, Brinjikji et al53 reported
further 24 701 patients with TTC; sepsis was considered the
cause in 7% of these patients.
Recently, the role of gender-based mechanisms contributing
to the association between TTC and sepsis has been discussed
in the literature.57 Here, the authors report that although TTC is
more prevalent in women and the great majority of the reported
clinical cases had a favorable outcome, a possible gender effect
in clinical outcome, especially on IHM in the presence of sep-
sis, could be possible and should be taken into account.57 As
support for this theory, Brinjikji et al,53 in their study on 24 701
cases with TTC (89.0%women), showed that male patients had
a higher mortality rate than women (11.0% vs 6.5%), and those
with sepsis as well (24.9% vs 20.8%). Moreover, Isogai et al,52
in a study carried out on 3719 patients, demonstrated that
patients with in-hospital TTC had a higher proportion of men
than out-of-hospital patients with TTC (31.3% vs 21.3%). In
conclusion, although TTC mostly affects women, men seem to
be exposed to a worst clinical outcome and higher IHM in the
presence of sepsis.
Possible Mechanisms of Sepsis-Related TTC
The pathophysiology of sepsis-induced TTC is complex. Four
major hypotheses on the pathogenesis have been discussed in
the literature; these could be defined as:
1. The role of sepsis-induced systemic inflammation,
which mediators of inflammation and products of
microbial derivation could lead to myocardial
dysfunction.40
2. The role of cardiac catecholamine toxicity.40
3. Exogenous administration of catecholamines in patients
having septic shock.32
4. Myocardial ischemia resulting from inadequate coron-
ary blood flow during sepsis.32
There are data suggesting that tumor necrosis factor a and
interleukin (IL) 1b and possibly other cytokines involved in
septic shock, which potentially mediate the myocardial depres-
sion in septic shock by several mechanisms.58 For example,
these may act as powerful trigger factors for TTC induction
through activation of the local cardiac sympathetic nervous
system leading to disruption of the cardiac sympathetic nerve
terminals and causing noradrenaline spillover.32 Our group
Figure 3. Frequency of type of takotsubo cardiomyopathy in relation
with (A) sex and (B) results obtained from the coronary angiography.
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demonstrated that IL-6 was the cardiodepressant factor in sep-
sis, acting via the myocardial depressant p38 mitogen-activated
protein kinase pathway that is common in patients with takot-
subo syndrome.59-61 In both sepsis and TTC, we had suggested
that the cardiodepression was linked to cardioprotective anti-
apoptotic/antiarrhythmic Gi-mediated signaling cascade.
With regard to the role of endogenous and exogenous (eg,
infusion of epinephrine or norepinephrine as a therapeutic
intervention) catecholamines in triggering TTC, their role is
well known in nonsepsis-induced TTC population62,63; this
model could also be used to explain the sepsis-induced TTC.
Indeed, sepsis produces an overstimulation of the sympathetic
nervous system and subsequent high levels of catecholamine
plasma levels. This would precipitate the b2 adrenoceptor-Gs
to Gi switch to result in takotsubo syndrome myocardial
depression.60 We had considered the possibility that patients
with takotsubo sepsis might be ‘‘inotrope-unresponsive’’
patients who had been given excess adrenaline. Such a mechan-
ism, however, may not be predominant in these patients as
many would have already been having TTC before being
admitted to an inotropic support environment (such as an
intensive care unit). Summarizing, sepsis-induced inflamma-
tion and related cytokines, high endogenous catecholamine
production, and the administered exogenous catecholamines
can be seen as triggering factors for inducing TTC through
activation of sympathetic nervous system.32
The pathophysiologic mechanisms involved in
catecholamine-induced cardiac toxicity may depend on inflam-
mation, oxidative stress, and abnormal calcium handling,
resulting in myocardial stunning, apoptosis, and necrosis.57
Reverse Takotsubo and Sepsis
Reverse TTC is a more recently recognized variant of the TTC
where, in the regional wall, motion abnormalities are localized to
the basal segments with hyperkinetic apical segments. From our
review, we described a case of a 41-year-old woman with an
echocardiogram diagnosis compatible with reverse TTC.19 Also,
for the reverse TTC, the clinical presentation may be indistin-
guishable from acute coronary syndrome and may include symp-
toms of chest pain, dyspnea, ECG changes of ischemia or acute
MI, and elevated cardiac and hemodynamic biomarkers.
Figure 4. Frequency of outcome (survived vs died) in patients with takotsubo cardiomyopathy in relation with (A) sex, (B) risk factors (absence
or presence), (C) results obtained from the coronary angiography, and (D) time interval of takotsubo presentation from admission.
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In order to explain this variant, it has been hypothesized that
variations in the density of adrenoceptors on the myocardium
account for the changes in the distribution of the wall motion
abnormalities. Indeed, a greater density of adrenoceptors in the
base may result in reverse TTC, whereas increased apical dis-
tribution results in classic TTC. Furthermore, it has been sug-
gested that the adrenoceptor density shifts with age from the
base to the apex of the heart.64 Reverse TTC also differs from
the classic form with respect to its hemodynamic and biochem-
ical profile. Indeed, reverse TTC is usually associated with
higher levels of cardiac biomarkers, perhaps due to the larger
area of myocardial involvement compared to the apical variant.
Despite this, we have not observed higher level of cardiac
biomarkers in the case of reverse TTC reported by Lee et al.19
Limitations
The present review has several limitations: first, only case
reports and case series on patients with TTC associated with
sepsis were screened; second, many papers only provided par-
tial data about the characteristics of patients and adopted pro-
cedures. The findings of this report must be substantiated in
larger studies, and until then the displayed information should
be regarded as hypothesis-generating observations.
Implications of the Study and Directions for Future
Research
Our main aim of this study was to address the knowledge gap of
almost total lack of research evidence on the relation between
sepsis and TTC.
This study offers the opportunity to refine and validate some
important concepts and theories. For example, the idea of an
association between sepsis and subsequent onset of TTC will
need further refinement and in-depth studies in terms of both
the microorganisms involved and the exact pathological
mechanisms involved. In the same way, future research should
emphasize the high frequency of false acute coronary syn-
drome diagnosis and how to early recognize these 2 different
pathologies; this is particularly important in terms of their dif-
ferential outcomes and treatments.
Furthermore, noteworthy is the necessity to avoid the great
amount of negative invasive examinations, such as coronary
angiography, that are routinely carried out in these patients; the
nonnegligible cost of such examinations, the potential risk of
in-hospital complication related to the unnecessary procedures,
and the following medicolegal problem that could arise should
also be taken into account.
Conclusion
Although the association between cardiomyopathy and sepsis
has been debated in previous papers, this systematic review
represents the greatest cohort of cases with sepsis-induced TTC
in the literature.
Findings obtained from our study further support the role of
catecholamines in the etiology of sepsis-induced TTC. It also
highlights its benign course and its prevalence among females.
There was insufficient data to suggest any gender-related
effects on outcome, although recent studies have highlighted
that men seemed to have a worse clinical outcome and higher
IHM in the presence of sepsis. For this reason, male patients
suspected for sepsis-induced TTC should be carefully moni-
tored in order to avoid harmful and life-threatening
consequences.
Awareness of the relationship between sepsis and TTC is
important as it can avoid diagnostic dilemmas, limit inap-
propriate examinations, and allow timely initiation of
supportive medical therapy. A better understanding of the
mechanisms of sepsis-associated TTC may aid in the genera-
tion of novel strategies to treat the complications of this poten-
tially lethal disease and may even help predict and prevent
its occurrence in patients most at risk of this specific
cardiomyopathy.
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